Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT HYDROBROMIDE vs NIRSEVIMAB-ALIP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIROGACESTAT HYDROBROMIDE vs NIRSEVIMAB-ALIP: Safety Overview

Metric NIROGACESTAT HYDROBROMIDE NIRSEVIMAB-ALIP
Total FAERS Reports 166 783
Deaths Reported 0 32
Death Rate N/A 4.1%
Hospitalizations 18 281
Average Patient Age 46.8 yrs 3.3 yrs
% Female Patients 63.0% 46.3%
FDA Approval Date Apr 4, 2024 N/A
Marketing Status Prescription Prescription